Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serumShenglin Cai, Joshua B. Edel, Charlotte L. Bevan et al.|Nature Communications|2021Cited by 236
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancerClaire Fletcher, Charlotte L. Bevan|Oncogene|2019Cited by 70
Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumoursD. Alwyn Dart, Charlotte L. Bevan|Endocrine Related Cancer|2009Cited by 56
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancerTheodora A. Constantin, Charlotte L. Bevan|British Journal of Cancer|2023Cited by 24
Integrative bioinformatics analyses to identify novel biomarkers and tissue-specific targets in adrenocortical cancer: a proof-of-concept studyJoshua Agilinko, Charlotte L. Bevan, Antinisca Di Marco et al.|British journal of surgery|2025Cited by 0